• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

What is Occluding Our Understanding of Retinal Vein Occlusion?

作者信息

Dinah Christiana, Chang Andrew, Lee Junyeop, Li William W, Singh Rishi, Wu Lihteh, Wong David, Saffar Insaf

机构信息

London North West University Healthcare NHS Trust, Northwick Park Hospital, London, UK.

Sydney Retina Clinic, Sydney Eye Hospital, Sydney University, Sydney, Australia.

出版信息

Ophthalmol Ther. 2024 Dec;13(12):3025-3034. doi: 10.1007/s40123-024-01042-6. Epub 2024 Oct 10.

DOI:10.1007/s40123-024-01042-6
PMID:39387960
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11564720/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd2/11564720/16970bc9c552/40123_2024_1042_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd2/11564720/16970bc9c552/40123_2024_1042_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1bd2/11564720/16970bc9c552/40123_2024_1042_Fig1_HTML.jpg

相似文献

1
What is Occluding Our Understanding of Retinal Vein Occlusion?是什么阻碍了我们对视网膜静脉阻塞的理解？
Ophthalmol Ther. 2024 Dec;13(12):3025-3034. doi: 10.1007/s40123-024-01042-6. Epub 2024 Oct 10.
2
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.Faricimab 治疗视网膜静脉阻塞所致黄斑水肿的疗效和安全性：BALATON 和 COMINO 试验的 24 周结果。
Ophthalmology. 2024 Aug;131(8):950-960. doi: 10.1016/j.ophtha.2024.01.029. Epub 2024 Jan 26.
3
Efficacy and Safety of Intravitreal Faricimab in Neovascular Age-Related Macular Degeneration, Diabetic Macular Edema, and Retinal Vein Occlusion: A Meta-Analysis.玻璃体内注射法西单抗治疗新生血管性年龄相关性黄斑变性、糖尿病性黄斑水肿和视网膜静脉阻塞的疗效与安全性：一项荟萃分析
Ophthalmologica. 2024;247(5-6):355-372. doi: 10.1159/000541662. Epub 2024 Oct 3.
4
BALATON and COMINO: Phase III Randomized Clinical Trials of Faricimab for Retinal Vein Occlusion: Study Design and Rationale.巴拉顿湖和科米诺岛：法西单抗治疗视网膜静脉阻塞的III期随机临床试验：研究设计与原理
Ophthalmol Sci. 2023 Mar 27;3(3):100302. doi: 10.1016/j.xops.2023.100302. eCollection 2023 Sep.
5
Intra-Ocular Inflammation and Occlusive Retinal Vasculitis Following Intravitreal Injections of Faricimab: A Case Report.玻璃体内注射法巴利昔单抗后眼内炎症和闭塞性视网膜血管炎：一例报告。
Ocul Immunol Inflamm. 2024 Dec;32(10):2544-2547. doi: 10.1080/09273948.2024.2361834. Epub 2024 Jun 10.
6
Faricimab Treat-and-Extend Dosing for Macular Edema Due to Retinal Vein Occlusion: 72-Week Results from the BALATON and COMINO Trials.法西单抗治疗并延长给药方案用于视网膜静脉阻塞所致黄斑水肿：BALATON和COMINO试验的72周结果
Ophthalmol Retina. 2025 Mar 17. doi: 10.1016/j.oret.2025.03.005.
7
Switching to Faricimab in Therapy-Resistant Macular Edema Due to Retinal Vein Occlusion: Initial Real-World Efficacy Outcomes.视网膜静脉阻塞所致治疗抵抗性黄斑水肿转换为使用法西单抗治疗：初始真实世界疗效结果
J Clin Med. 2025 Apr 3;14(7):2454. doi: 10.3390/jcm14072454.
8
Faricimab: First Approval.法西单抗：首次获批。
Drugs. 2022 May;82(7):825-830. doi: 10.1007/s40265-022-01713-3.
9
Emerging clinical evidence of a dual role for Ang-2 and VEGF-A blockade with faricimab in retinal diseases.法西单抗阻断血管生成素-2（Ang-2）和血管内皮生长因子-A（VEGF-A）在视网膜疾病中的双重作用的新临床证据。
Graefes Arch Clin Exp Ophthalmol. 2024 Dec 21. doi: 10.1007/s00417-024-06695-4.
10
VEGF-Aa and angiopoietin-2 differently affect the barrier formed by retinal endothelial cells.VEGF-Aa 和血管生成素-2 对视网膜内皮细胞形成的屏障有不同的影响。
Exp Eye Res. 2024 Oct;247:110062. doi: 10.1016/j.exer.2024.110062. Epub 2024 Aug 24.

引用本文的文献

1
Jueling Mingmu decoction combined with ranibizumab for retinal vein occlusion induced macular edema: A randomized controlled clinical trial.菊苓明目汤联合雷珠单抗治疗视网膜静脉阻塞性黄斑水肿的随机对照临床试验
Int Ophthalmol. 2025 Sep 2;45(1):372. doi: 10.1007/s10792-025-03738-5.

本文引用的文献

1
Multi-risk factors joint prediction model for risk prediction of retinopathy of prematurity.早产儿视网膜病变风险预测的多风险因素联合预测模型
EPMA J. 2024 May 9;15(2):261-274. doi: 10.1007/s13167-024-00363-7. eCollection 2024 Jun.
2
Efficacy and Safety of Faricimab for Macular Edema due to Retinal Vein Occlusion: 24-Week Results from the BALATON and COMINO Trials.Faricimab 治疗视网膜静脉阻塞所致黄斑水肿的疗效和安全性：BALATON 和 COMINO 试验的 24 周结果。
Ophthalmology. 2024 Aug;131(8):950-960. doi: 10.1016/j.ophtha.2024.01.029. Epub 2024 Jan 26.
3
Evaluating the long-term biological stability of cytokine biomarkers in ocular fluid samples.
评估眼内液样本中细胞因子生物标志物的长期生物学稳定性。
BMJ Open Ophthalmol. 2023 Dec 11;8(1):e001346. doi: 10.1136/bmjophth-2023-001346.
4
Angiopoietin-2 Promotes Mechanical Stress-induced Extracellular Matrix Degradation in Annulus Fibrosus Via the HIF-1α/NF-κB Signaling Pathway.血管生成素-2 通过 HIF-1α/NF-κB 信号通路促进纤维环的机械应激诱导的细胞外基质降解。
Orthop Surg. 2023 Sep;15(9):2410-2422. doi: 10.1111/os.13797. Epub 2023 Jul 21.
5
High Variation in Inner Retinal Reflectivity Predicts Poor Visual Outcome in Patients With Central Retinal Vein Occlusion: SCORE2 Report 21.高内视网膜反射性差异预示着视网膜中央静脉阻塞患者的视觉预后不良：SCORE2 报告 21 期。
Transl Vis Sci Technol. 2023 Jun 1;12(6):21. doi: 10.1167/tvst.12.6.21.
6
Foveal Eversion is Associated with High Persistence of Macular Edema and Visual Acuity Deterioration in Retinal Vein Occlusion.黄斑反转与视网膜静脉阻塞时黄斑水肿的高持续性及视力恶化相关。
Ophthalmol Ther. 2023 Aug;12(4):2157-2169. doi: 10.1007/s40123-023-00734-9. Epub 2023 Jun 9.
7
SCORE2 Report 24: Nonlinear Relationship of Retinal Thickness and Visual Acuity in Central Retinal and Hemiretinal Vein Occlusion.SCORE2 报告 24：视网膜中央和半侧视网膜静脉阻塞中视网膜厚度与视力的非线性关系。
Ophthalmology. 2023 Oct;130(10):1066-1072. doi: 10.1016/j.ophtha.2023.05.023. Epub 2023 May 21.
8
Changes in Aqueous and Vitreous Inflammatory Cytokine Levels in Retinal Vein Occlusion: A Systematic Review and Meta-analysis.视网膜静脉阻塞中房水和玻璃体内炎性细胞因子水平的变化：一项系统评价和荟萃分析。
J Vitreoretin Dis. 2019 Oct 31;4(1):36-64. doi: 10.1177/2474126419880391. eCollection 2020 Jan-Feb.
9
Update on Retinal Vein Occlusion.视网膜静脉阻塞的最新进展
Asia Pac J Ophthalmol (Phila). 2023;12(2):196-210. doi: 10.1097/APO.0000000000000598. Epub 2023 Feb 14.
10
Red Blood Cells: A Newly Described Partner in Central Retinal Vein Occlusion Pathophysiology?红细胞：在中央视网膜静脉阻塞发病机制中一个新描述的伙伴？
Int J Mol Sci. 2023 Jan 5;24(2):1072. doi: 10.3390/ijms24021072.